<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixty patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> of various etiology at the stage of <z:hpo ids='HP_0001394'>hepatic cirrhosis</z:hpo> with <z:hpo ids='HP_0002480'>hepatic encephalopathy</z:hpo> syndrome (HES), thirty patients with cerebral <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> with dyscirculatory <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (DE) and 60 healthy controls have been examined in the study of basic diagnostic criteria of <z:hpo ids='HP_0001298'>encephalopathies</z:hpo> by <z:chebi fb="0" ids="26666">short-chain fatty acids</z:chebi> (SCFA) serum levels </plain></SENT>
<SENT sid="1" pm="."><plain>Sensitivity and specificity of this test was also evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>Gas-liquid chromatography determined SCFA in the feces and peripheral blood serum from the above examinees </plain></SENT>
<SENT sid="3" pm="."><plain>It was found that relative consent of SCFA and for the most part profiles of propionic and fat acids, acids with long chains, SCFA isomers in patients with <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> of different genesis correlate with the results of clinical, laboratory and psychometric methods of examination and should be used together </plain></SENT>
<SENT sid="4" pm="."><plain>Basic criteria are devised </plain></SENT>
</text></document>